Table 1.
Descriptive statistics of the variables and testing for differences between the groups
| Variables | Group 1 (n = 68, parities < 5) |
Group 2 (n = 66, parities ≥ 5) |
p |
|---|---|---|---|
| Age, mean ± SD | 47.94 ± 8.07 | 48.15 ± 6.42 | 0.552* |
| BMI, mean ± SD | 28.71 ± 3.54 | 30.19 ± 3.82 | 0.440* |
| Disease duration (months), mean ± SD | 5.55 ± 2.67 | 10.54 ± 5.22 | < 0.01* |
| VAS score, mean ± SD | 6.50 ± 1.61 | 8.42 ± 1.34 | < 0.01* |
| ODI score, mean ± SD | 18.41 ± 7.97 | 29.87 ± 6.75 | < 0.01* |
| Modic change, n (%) | |||
| None | 17 (25) | 4 (6.1) | < 0.05# |
| Type 1 | 37 (54.4) | 30 (45.5) | |
| Type 2 | 14 (20.6) | 32 (48.5) | |
| Type 3 | 0 (0.0) | 0 (0.0) | |
| Schmorl’s nodes, n (%) | |||
| None | 46 (67.6) | 26 (39.4) | < 0.0& |
| Yes | 22 (32.4) | 40 (60.6) | |
| Sacral slope, mean ± SD | 41.01 ± 8.42 | 39.29 ± 7.21 | 0.373* |
| Pelvic tilt, mean ± SD | 15.24 ± 7.31 | 15.05 ± 6.08 | 0.906* |
| Pelvic incidence, mean ± SD | 62.67 ± 11.17 | 58.90 ± 10.30 | 0.156* |
| L1-S1 lordosis angle, mean ± SD | 53.36 ± 12.02 | 55.62 ± 12.80 | 0.459* |
| L1-L2 lordosis angle, mean ± SD | 3.86 ± 2.75 | 4.39 ± 2.73 | 0.431* |
| L2-L3 lordosis angle, mean ± SD | 7.23 ± 3.54 | 6.95 ± 3.91 | 0.757* |
| L3-L4 lordosis angle, mean ± SD | 10.68 ± 4.41 | 11.23 ± 6.17 | 0.675* |
| L4-L5 lordosis angle, mean ± SD | 20.27 ± 7.27 | 18.03 ± 6.98 | 0.203* |
| L5-S1 lordosis angle, mean ± SD | 21.80 ± 7.13 | 21.72 ± 7.41 | 0.963* |
ODI Oswestry Disability Index, VAS visual analog scale, BMI body mass index
*Independent t test
#Fisher Freeman Halton Test
&Chi-Square test